The Ensign Group to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 19, 2026

Rhea-AI Summary

The Ensign Group (NASDAQ: ENSG) will present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 19, 2026 at 10:40 a.m. Eastern Time.

Executives presenting include CEO Barry Port, CFO Suzanne Snapper, CIO Chad Keetch, and Adam Willits of Flagstone Healthcare. A live webcast will be available and archived for approximately 90 days.

Key Figures

Conference date: March 19, 2026 Presentation time: 10:40 a.m. Eastern Time Facilities: 378 healthcare facilities +2 more

5 metrics

Conference date March 19, 2026 Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Presentation time 10:40 a.m. Eastern Time Scheduled time for company presentation on March 19, 2026

Facilities 378 healthcare facilities Number of facilities operated across listed U.S. states

States served 17 states States where Ensign’s operating subsidiaries provide services

Webcast archive duration 90 days Length of time the conference webcast will remain available

Market Reality Check

Price: $208.36 Vol: Volume 256,133 is 0.68x t...

low vol

$208.36 Last Close

Volume Volume 256,133 is 0.68x the 20-day average of 379,239, indicating subdued trading ahead of the conference. low

Technical Shares at $210.43 are trading above the 200-day MA of $172.73 and about 3.47% below the 52-week high of $218.

Peers on Argus

ENSG was up 0.37% with muted volume while key peers like DVA (+3.14%), CHE (+0.9...

ENSG was up 0.37% with muted volume while key peers like DVA (+3.14%), CHE (+0.96%), OPCH (+0.98%) and UHS (+0.70%) also gained; EHC declined 5.7%, suggesting mixed but generally constructive sector action rather than a unified move tied to this conference notice.

Common Catalyst Multiple medical care peers, including CHE, also released conference participation updates, pointing to a broader investor focus on healthcare presentations rather than company-specific catalysts.

Historical Context

5 past events · Latest: Feb 04 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 04	Earnings and guidance	Positive	+13.8%	Strong 2025 results with higher 2026 EPS and revenue guidance.
Feb 03	Acquisitions Arizona/Texas	Positive	+0.6%	Expanded operations and real estate, lifting network to 378 facilities.
Feb 03	Texas/Wisconsin deals	Positive	+0.6%	Acquired multiple skilled nursing properties and operations in TX and WI.
Feb 03	Wisconsin acquisition	Positive	+0.6%	Bought Timber Ridge facility real estate and operations, expanding footprint.
Feb 03	Multi-state acquisitions	Positive	+0.6%	Closed several TX and AZ deals, reaching 378 operations in 17 states.

Pattern Detected

Recent earnings and acquisition announcements have generally been followed by positive price reactions.

Recent Company History

Over recent months, Ensign has combined strong financial performance with steady portfolio expansion. On Feb 4, 2026, it reported 2025 GAAP diluted EPS of $5.84, adjusted EPS of $6.57, GAAP net income of $344.0M, and revenue of $5.06B, issuing 2026 EPS guidance of $7.41–$7.61 and revenue of $5.77B–$5.84B. Around Feb 1, 2026, multiple acquisitions in Texas, Wisconsin, and Arizona lifted the portfolio to 378 healthcare operations and 160 real estate assets across 17 states. Today’s conference appearance fits an established pattern of communicating growth and strategy to investors.

Market Pulse Summary

This announcement simply highlights Ensign’s participation in a healthcare investor conference, wher...

Analysis

This announcement simply highlights Ensign’s participation in a healthcare investor conference, where leadership planned to discuss operations and growth strategy. It reinforces the scale of the platform, with 378 healthcare facilities across 17 states, following recent acquisitions and strong 2025 results. Investors tracking the story may focus on management’s qualitative commentary versus prior guidance, the evolution of its acquisition pipeline, and how the company frames regulatory and reimbursement risks noted in its forward-looking statements.

Key Terms

skilled nursing, safe harbor statement, forward-looking statements

3 terms

skilled nursing medical

"provide skilled nursing and senior living services, physical, occupational..."

Skilled nursing is a higher level of medical care provided in a facility for people who need daily, professional clinical services—such as wound care, intravenous treatments, medication management, or physical therapy—rather than only basic assistance with daily tasks. For investors, it matters because skilled nursing services are typically billed at higher rates, subject to specific insurance and government reimbursement rules, and drive a facility’s revenue, occupancy and regulatory risk much like a specialized department does for a hospital.

safe harbor statement regulatory

"Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:"

A safe harbor statement is a disclaimer that companies include in their public disclosures to limit legal liability if future results differ from what was forecasted or expected. It acts like a protective shield, helping companies avoid lawsuits if their predictions don’t come true, and gives investors a clearer understanding that certain statements are forward-looking and involve risks.

forward-looking statements regulatory

"This presentation and webcast may contain forward-looking statements that are based on..."

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

AI-generated analysis. Not financial advice.

SAN JUAN CAPISTRANO, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign^™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it will participate in the Oppenheimer 36^th Annual Healthcare MedTech & Services Conference on Thursday, March 19, 2026.

Barry Port, Chief Executive Officer and Chairman of the Board; Suzanne Snapper, Chief Financial Officer; Chad Keetch, Chief Investment Officer; and Adam Willits President of Flagstone Healthcare North LLC, Flagstone Healthcare Central LLC, and Flagstone Healthcare South LLC, Ensign’s California-based subsidiaries will present on the company's operations, growth strategy and related information at 10:40 a.m. Eastern Time on March 19, 2026.

The live webcast will be available at:

https://event.summitcast.com/view/2MZVg3DCx8a3zxe3mMMekq/S26LmQTsCjyN9Vr3Ri49XC

The webcast will automatically be archived approximately an hour after the live event and will be available at this link for 90 days.

About Ensign^™

The Ensign Group, Inc.'s independent operating subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at 378 healthcare facilities, in Alabama, Alaska, Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. More information about Ensign is available at http://www.ensigngroup.net.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This presentation and webcast may contain forward-looking statements that are based on management’s current expectations, assumptions and beliefs about its business, financial performance, operating results, the industry in which it operates and other future events. Forward-looking statements can often be identified by words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "could," "potential," "continue," "ongoing," similar expressions, and variations or negatives of these words. These forward-looking statements include, but are not limited to, statements regarding growth prospects, future operating and financial performance, and acquisition activities. They are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to materially and adversely differ from those expressed in any forward-looking statement.

These risks and uncertainties relate to the Company’s business, its industry and its common stock and include: reduced prices and reimbursement rates for its services; its ability to acquire, develop, manage or improve operations, its ability to manage its increasing borrowing costs as it incurs additional indebtedness to fund the acquisition and development of operations; its ability to access capital on a cost-effective basis to continue to successfully implement its growth strategy; its operating margins and profitability could suffer if it is unable to grow and manage effectively its increasing number of operations; competition from other companies in the acquisition, development and operation of facilities; its ability to defend claims and lawsuits, including professional liability claims alleging that our services resulted in personal injury, and other regulatory-related claims; and the application of existing or proposed government regulations, or the adoption of new laws and regulations, that could limit its business operations, require it to incur significant expenditures or limit its ability to relocate its operations if necessary. Additionally, our business and operations continue to be impacted by the unprecedented nature of the changes in the regulations and environment, as such, we are unable to predict the full extent and duration of the financial impact of these changes on our business, financial condition and results of operations. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various factors. Readers should not place undue reliance on any forward-looking statements and are encouraged to review the Company’s periodic filings with the Securities and Exchange Commission, including its Form 10-Q and 10-K, for a more complete discussion of the risks and other factors that could affect Ensign’s business, prospects and any forward-looking statements. Except as required by the federal securities laws, Ensign does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changing circumstances or any other reason after the date of this press release.

Contact Information

The Ensign Group, Inc., (949) 487-9500, ir@ensigngroup.net

SOURCE: The Ensign Group, Inc.

FAQ

When will Ensign (ENSG) present at the Oppenheimer Healthcare MedTech & Services Conference?

Ensign (NASDAQ: ENSG) will present on March 19, 2026 at 10:40 a.m. Eastern Time. According to the company, the presentation will feature CEO Barry Port and other senior leaders discussing operations, growth strategy, and related information; a webcast will be available and archived for 90 days.

Who from Ensign (ENSG) will speak at the March 19, 2026 conference presentation?

Speakers include CEO Barry Port, CFO Suzanne Snapper, CIO Chad Keetch, and Adam Willits. According to the company, these executives will present the firm's operations, growth strategy and related information during the session and Q&A period.

How can investors watch Ensign (ENSG) present at the Oppenheimer conference on March 19, 2026?

Investors can view a live webcast at the provided SummitCast link during the March 19, 2026 presentation. According to the company, the webcast will be archived about an hour after the live event and remain available at the same link for 90 days.

What topics will Ensign (ENSG) cover in its March 19, 2026 presentation?

Ensign will discuss the company’s operations, growth strategy and related information during the presentation. According to the company, management intends to address operational details, strategic priorities and insights relevant to investors and stakeholders.

How long will the Ensign (ENSG) webcast of the March 19, 2026 presentation remain available?

The webcast will be archived and available for approximately 90 days after the event. According to the company, the live stream will be archived about an hour after the presentation and remain accessible at the same link for investor review for three months.